Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...
Fibrosis lacks treatments and methods of reversal: Study pinpoints a promising target for drug therapy
Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...
Becker's Hospital Review10h
13 drugs expected to be included in CMS negotiations: Study
The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.
Le Lézard21h
InstantGMPtm Achieves ISO 9001 Certification, Elevating Standards for Quality Management
InstantGMPtm, a leading provider of software solutions for pharmaceutical manufacturing, proudly announces that it has achieved ISO 9001 certification. This certification, recognized worldwide, ...
Le Lézard20h
Fellowship-trained Head and Neck Surgical Oncologist and Microvascular Reconstructive Surgeon Joins Karmanos in Detroit and Flint
The Barbara Ann Karmanos Cancer Institute welcomes Nithin Peddireddy, M.D., a head and neck surgical oncologist specializing in benign and malignant head and neck neoplasms. These include mouth, jaw, ...
Anti-inflammatory drug shows promise in boosting motivation for patients with depression, study reveals
A new study published this week in Molecular Psychiatry by Emory University researchers has revealed a promising new avenue ...